Business Context and Reporting Period
This Form 8-K, dated January 25, 2021, is filed by Foley Trasimene Acquisition Corp. (FTAC), a Delaware corporation and emerging growth company. The filing announces the entry into a Business Combination Agreement with Tempo Holding Company, LLC, the parent company of Alight Solutions (Alight). The filing also discloses a concurrent private placement of $1.55 billion in connection with the proposed transaction.
Key Financial Metrics
The filing text does not provide specific historical revenue, profit, cash flow, margin, or debt figures for either FTAC or Alight. The only specific financial metric disclosed is the $1.55 billion private placement associated with the business combination. FTAC's securities registered on the New York Stock Exchange include Units (WPF.U), Class A common stock (WPF), and Warrants (WPF WS) with an exercise price of $11.50 per share.
Material Changes
The primary material change is the strategic shift from a standalone special purpose acquisition company (SPAC) to a combined entity with Alight Solutions. This represents a significant corporate restructuring event rather than a change in operational financial performance for the reporting period.
Guidance, Outlook, and Risks
Management commentary is limited to the announcement of the agreement and the private placement. Detailed terms of the Business Combination Agreement are reserved for a subsequent Form 8-K filing. The filing includes an investor presentation (Exhibit 99.2) intended for use in connection with the combination. The registrant explicitly states that the information furnished in Item 7.01 and its exhibits is not deemed "filed" for purposes of Section 18 of the Exchange Act and shall not be incorporated by reference into other filings, limiting the legal liability of the disclosed information.
Investor Verification Checklist
- Verify the definitive terms of the Business Combination Agreement in the subsequent Form 8-K filing.
- Review the $1.55 billion private placement terms and investor commitments.
- Examine the investor presentation (Exhibit 99.2) for projected financials and strategic rationale.
- Confirm the status of shareholder approval requirements for the business combination.
- Monitor for any updates regarding the exercise price of $11.50 per share for the warrants.